{"id":"W4403231995","doi":"10.1080/03007995.2024.2409837","title":"Patient-reported outcomes in patients with relapsed or refractory follicular lymphoma treated with zanubrutinib plus obinutuzumab versus obinutuzumab monotherapy: results from the ROSEWOOD trial","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"BeiGene","keywords":"Medicine; Obinutuzumab; Internal medicine; Refractory (planetary science); Oncology; Follicular lymphoma; Lymphoma; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001749101,0.0004479583,0.0007805069,0.0004013614,0.0002552005,0.0001981555,0.0003854888,0.0003701492,0.0001892722],"category_scores_gemma":[0.005321801,0.0002126862,0.0001203076,0.001387534,0.0008569527,0.0002159601,0.0002486,0.00146229,0.0000374856],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01927108,"about_ca_system_score_gemma":0.03516641,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003750071,"about_ca_topic_score_gemma":0.0003520619,"domain_scores_codex":[0.9909689,0.0006394861,0.000973214,0.001215203,0.005053926,0.001149241],"domain_scores_gemma":[0.9927164,0.004729726,0.0001422987,0.00104047,0.0004388902,0.0009321612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8057775,0.001101383,0.003013753,0.0002344951,0.0008144033,0.001330643,0.00172613,0.00000609971,0.00000428466,0.0000727053,0.004856939,0.1810616],"study_design_scores_gemma":[0.8793908,0.0280097,0.01908161,0.004953219,0.0001049521,0.00003961502,0.000578112,0.01105315,0.00007675918,0.00005529165,0.05615802,0.0004987791],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908764,0.003350557,0.00001586138,0.0008369933,0.001026603,0.00340164,0.0001277484,0.0001280912,0.0002360658],"genre_scores_gemma":[0.9951338,0.002489475,0.00003245766,0.00005099547,0.0004872131,0.0003436404,0.001165365,0.0000864227,0.0002105888],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1805629,"threshold_uncertainty_score":0.9844938,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07134928530396044,"score_gpt":0.3822081702828955,"score_spread":0.310858884978935,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}